MedTrace Logo

Efficacy and Safety of Irlanda-2 Association on the Treatment of Common Cold

NCT02656914 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2019-10-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical efficacy of the drug associations in the treatment of common cold

Conditions

  • Common Cold

Interventions

DRUG

Irlanda-2-Association

Take 10 mL every 12 hours (2x/day), oral route.

DRUG

Placebo

Take 10 mL every 12 hours (2x/day), oral route.

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-30
Primary Completion
2020-06-30
Completion
2020-09-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02656914 on ClinicalTrials.gov